To investigate the impact of SETD2 loss-induced transcriptome changes on the pathogenesis of KrasG12D-driven lung cancer, RNA-Seq was performed on KrasG12D and KrasG12DSetd2–/– lung tumors with comparable histopathological features and tumor grades (Supplemental Figure 1E). This evidence concerns the gene SETD2 and lung cancer.